Eyenovia to Participate in a Presbyopia Panel Discussion at Eyecelerator 2021
Eyenovia, Inc. (
NASDAQEYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, today announced that Eyenovia will be featured at the Company Showcase on July 22 at the Eyecelerator@ASCRS and will participate in a panel discussion, entitled, “Presbyopia: Everybody gets it... but can it be fixed?”
